GMT Capital’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$867K Buy
+296,905
New +$948K 0.04% 69
2023
Q4
– Sell
-296,905
Closed -$433K – 102
2023
Q3
$433K Hold
296,905
– – 0.02% 95
2023
Q2
$466K Hold
296,905
– – 0.02% 83
2023
Q1
$454K Buy
+296,905
New +$529K 0.02% 73

Other funds holding NAGE

GMT Capital's NAGE Position: Q3 2026 in Review

GMT Capital opened a new position in Niagen Bioscience (NAGE) in Q3 2026: 296,905 shares worth $867K. The stake represents 0.04% of the portfolio and ranks #69 among its holdings. This is a return to the name: GMT Capital previously reported a position in NAGE as recently as Q3 2023.

GMT Capital first reported a position in NAGE in Q1 2023 and has held it in 4 quarters since. 123 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

  • GMT Capital held 296,905 shares of Niagen Bioscience worth $867K as of Q3 2026.
  • Niagen Bioscience was a new GMT Capital position in Q3 2026.
  • Niagen Bioscience made up 0.04% of GMT Capital's portfolio in Q3 2026, its #69 holding.
  • GMT Capital first reported a position in Niagen Bioscience in Q1 2023 and has held it in 4 quarters since.
  • 123 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on GMT Capital's 13F filing for Q3 2026, filed 16 Nov 2026.